CME Group Inc. CME recently declared the first trade of the Used Cooking Oil Methyl Ester (UCOME) futures contracts.
As the European energy markets continue to evolve and decarbonize, there is a greater focus on renewable road transport fuels.
Ten contracts were traded on Sep 16, 2020. Open interest contracts traded were 65 as of Sep 22, 2020.
From January 2021, the renewable content in biodiesel is expected to be 14%, up from the current 10%, with increasing focus on waste oils as part of this strategy. Therefore, Used Cooking Oil (UCO) products are in focus.
Biodiesel blenders are using greater quantities in European products, and UCO is also being used in larger quantities in greener diesel products such as hydrotreated vegetable oil (HVO). These changes are creating demand for risk-based hedging tools to manage greater exposure to these emerging renewable fuels.
Specifically-designed futures contracts are used to manage the basis spreads between UCO and UCOME against Low Sulphur Gasoil futures. To support the transition to a greener energy market for transportation fuels, CME Group is offering four futures contracts for UCO and UCOME.
NYMEX, one of the exchanges of CME Group, which offers the widest range of global benchmark products across all major asset classes, introduced four futures contracts on UCO and UCOME on Aug 17, 2020. These new futures contracts extend the environmental, social, and governance (ESG) of CME Group and renewables offering outside North America and should attract interest from both energy and agricultural customers (existing and new).
Tullett Prebon Energy & Commodities, one of the world's leading interdealer brokers operating as an intermediary in the wholesale financial and energy sectors, became the first broker to transact Europe's first UCOME derivatives contracts between two counterparties.
The contracts are based on a UCO CIF ARA price assessment by PRIMA Markets and a UCOME FOB ARA assessment by Argus Media. Additionally, two spread based futures contracts against Low Sulphur Gasoil will also be listed.
The newly launched UCO and UCOME futures contracts will add to CME Group's robust suite of energy futures and options.
CME Group exchange consists of designated contract markets for the trading of futures and options contracts. It enables clients to trade futures, options, cash and over-the-counter (OTC) markets and optimize portfolios. It focuses on maximizing futures and options growth globally, diversifying business and revenues, and delivering unparalleled customer efficiencies and operational excellence.
The company offers the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), agricultural, energy and metal commodities. Futures and options trading are offered across asset classes through the CME Globex platform, cash and repo fixed income trading via BrokerTec, and cash and OTC FX trading via EBS.
Shares of this largest futures exchange in the world in terms of trading volume as well as notional value traded has declined 24% in the past year compared with the industry’s decline of 5.3%. Nonetheless, the company’s policy to ramp up its growth profile and capital position should continue to drive shares higher.
The stock currently carries a Zacks Rank #4 (Sell).
Stocks to Consider
Some better-ranked stocks from the finance sector include MoneyGram International Inc. MGI, OTC Markets Group Inc. OTCM and Virtu Financial, Inc. VIRT. While MoneyGram carries a Zacks Rank #1 (Strong Buy), OTC Markets and Virtu Financial carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
MoneyGram surpassed estimates in two of the last four quarters, with the average earnings surprise being 14.77%.
OTC Markets surpassed estimates in three of the last four quarters, with the average earnings beat being 10.54%.
Virtu Financial surpassed estimates in three of the last four quarters, with the average earnings beat being 10.19%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CME Group Inc. (CME) : Free Stock Analysis Report
MoneyGram International Inc. (MGI) : Free Stock Analysis Report
Virtu Financial, Inc. (VIRT) : Free Stock Analysis Report
OTC Markets Group Inc. (OTCM) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research